全文获取类型
收费全文 | 6334篇 |
免费 | 505篇 |
国内免费 | 228篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 115篇 |
妇产科学 | 207篇 |
基础医学 | 809篇 |
口腔科学 | 65篇 |
临床医学 | 733篇 |
内科学 | 647篇 |
皮肤病学 | 55篇 |
神经病学 | 47篇 |
特种医学 | 157篇 |
外国民族医学 | 3篇 |
外科学 | 1518篇 |
综合类 | 1003篇 |
现状与发展 | 2篇 |
预防医学 | 153篇 |
眼科学 | 19篇 |
药学 | 372篇 |
3篇 | |
中国医学 | 115篇 |
肿瘤学 | 991篇 |
出版年
2024年 | 11篇 |
2023年 | 115篇 |
2022年 | 139篇 |
2021年 | 243篇 |
2020年 | 220篇 |
2019年 | 180篇 |
2018年 | 185篇 |
2017年 | 221篇 |
2016年 | 248篇 |
2015年 | 246篇 |
2014年 | 346篇 |
2013年 | 445篇 |
2012年 | 300篇 |
2011年 | 345篇 |
2010年 | 283篇 |
2009年 | 293篇 |
2008年 | 271篇 |
2007年 | 330篇 |
2006年 | 276篇 |
2005年 | 293篇 |
2004年 | 235篇 |
2003年 | 210篇 |
2002年 | 184篇 |
2001年 | 176篇 |
2000年 | 135篇 |
1999年 | 126篇 |
1998年 | 101篇 |
1997年 | 104篇 |
1996年 | 101篇 |
1995年 | 83篇 |
1994年 | 79篇 |
1993年 | 51篇 |
1992年 | 63篇 |
1991年 | 38篇 |
1990年 | 50篇 |
1989年 | 35篇 |
1988年 | 30篇 |
1987年 | 26篇 |
1986年 | 29篇 |
1985年 | 41篇 |
1984年 | 27篇 |
1983年 | 32篇 |
1982年 | 33篇 |
1981年 | 27篇 |
1980年 | 17篇 |
1979年 | 14篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1976年 | 3篇 |
1975年 | 4篇 |
排序方式: 共有7067条查询结果,搜索用时 15 毫秒
21.
小鼠肝癌细胞H22对淋巴内皮细胞flt-4、c-fos、PCNA表达的影响 总被引:2,自引:1,他引:1
目的:初步探讨有自发淋巴转移特性的肝癌细胞对淋巴内皮细胞增殖的影响。方法:弗氏不完全佐剂诱导Balb/c小鼠腹腔良性淋巴管瘤,分离瘤体消化法体外培养淋巴内皮细胞;H22细胞接种Balb/c小鼠腹腔,收集腹水制成H22条件培养液,观察其对淋巴内皮细胞生长和表达flt-4、c-fos、PCNA的影响。结果:小鼠淋巴管瘤来源的淋巴内皮细胞可成单层贴壁培养,在内皮细胞完全培养液和H22条件培养液作用下可增殖达到或接近铺满状态,并阳性表达flt-4、c-fos、PCNA,普通培养液不能支持细胞生长,flt-4等染色为阴性:结论:淋巴内皮细胞增殖可能是癌细胞淋巴路转移的必要条件。 相似文献
22.
23.
SUMMARY: Peritonitis and exit‐site infections remain the most important limitations to the delivery of continuous ambulatory peritoneal dialysis (CAPD). Contamination of the peritoneum, from endogenous or exogenous sources, is responsible for most peritonitis episodes. Patients usually present with a cloudy bag, although other causes should be distinguished. Clinical suspicion of peritonitis should be followed rapidly by microbiological examination and empirical treatment. Microbiological confirmation allows for subsequent treatment based on sensitivities. Other interventions such as catheter removal may be appropriate in some patients. Exit‐site infections should also be identified and treated early. Peritonitis may be further prevented by adequate exit‐site care, hygienic methods, and techniques to minimise early contamination of the exit site. Mupirocin may also have a role in preventing infections caused by Staphylococcus aureus. 相似文献
24.
In order to investigate the effect of ligustrazine (Lig)i.p.on peritoneal permeability in peritoneal dialysis and its side effects,creatinine was given intravenously and continuously to maintain the high plasma creatinine level.All the rabbits were divided into three groups:normal control group (goup A),group B treated with 0.12% Lig and group C treated with 0.24% Lig.The peritoneal dialysis of all rabbits lasted 2h.The plasma and dialysate levels of glucose,protein and creatining were observed immediate,30min,60min,90min,120min after dialysis.Creastinine dialysate/plasma ratio (D/P),protein D/P ratio,grucose D/Do at different time points after dialysis and creatinine mass transfer area coefficient (MTAC) at 120min were calculated.The structures of peritoneum were observed under optical microscope and electron microscope after continuously intraperitoneal injection of Lig for 14 days.The results showed that the 90-min and 12-min creatinine D/P ratios in the group C were higher than in the group A.The 120-min creatinine MATC in the group C was higher than in the group A.The rabbits treated with Lig did not show significant structure changes of peritoneum and signs of peritoneal irritation.It was suggested that Lig could increase mass transfer ability of peritoneum without significant side effects. 相似文献
25.
Fatoş Yalçınkaya Necmiye Tümer Nilgün Çakar Nuray Özkaya 《Pediatric nephrology (Berlin, Germany)》1997,11(3):350-352
Hypertension is one of the most important complications of erythropoietin (rHuEPO) therapy in dialysis patients. In this
study, the effect of two different dosage regiments of subcutaneous rHuEPO on blood pressure [BP] was evaluated in 20 anemic
children on continuous ambulatory peritoneal dialysis (CAPD). Patients were randomized to receive rHuEPO 50 U/kg, either once
a week (group 1, 50 U/kg per week) or three times a week (group 2, 150 U/kg per week). At the beginning of the study, 8 patients
in group 1 and 8 patients in group 2 were on antihypertensive therapy. In group 1, the hematocrit increased gradually and
significantly from 18.98%±1.79% to 30.1%±1.62% after 6 months, while in group 2 it rapidly increased from 19.53%±1.86% to
32.4%±1.11% after 3 months. A significant increase in the mean arterial BP was observed in group 2. Antihypertensive therapy
had to be increased in all of the 8 previously hypertensive patients and had to be initiated in 1 of the 2 originally normotensive
patients in the same group. None of the patients in group 1 required a change in antihypertensive medication. We conclude
that during treatment with rHuEPO pre-existing hypertension and the dose of rHuEPO are the most important risk factors for
the development or worsening of hypertension in children on CAPD, and gradual elevation of hematocrit by low-dose rHuEPO avoids
the development of severe hypertension.
Received December 11, 1995; received in revised form September 16, 1996; accepted September 19, 1996 相似文献
26.
Based upon detailed dissections of the lymphatic system in adult cadavers, the lymphatic drainage of the gallbladder was divided
into three pathways: (1) The cholecystoretropancreatic pathway, which had two routes, one running spirally from the anterior
surface of the common bile duct to the right rear, and the other running almost straight down from the posterior surface of
the common bile duct. These routes converged at the principal retroportal node at the posterior surface of the head of the
pancreas. (2) The cholecysto-celiac pathway; this was the route running to the left through the hepatoduodenal ligament to
reach the celiac nodes. (3) The cholecysto-mesenteric pathway; this was the route running to the left in front of the portal
vein to connect with the nodes at the superior mesenteric root. The cholecysto-retropancreatic pathway can be regarded as
the main pathway, and the principal retroportal node appeared to be critical as the main terminal node in the visceral lymphatic
system of the gallbladder. These three pathways converged with the abdomino-aortic lymph nodes near the left renal vein, and
the nodes in the interaortico-caval space were considered to be of particular importance.
Offprint requests to: M. Ito 相似文献
27.
Hideaki Anai Yoshihiko Maehara Tatsuo Oshiro Hideo Baba Hiroyuki Orita Toshiro Okuyama Keizo Sugimachi 《Journal of surgical oncology》1993,53(3):204-207
In 268 of the 1,115 patients (24.0%) with gastric cancer who underwent a curative resection in our clinics, the tumor was located in the middle third of the stomach. The clinicopathological features and prognosis of these patients were divided into two groups, according to site of the tumor: anterior wall (n = 58) vs. other sites (n = 210). Clinicopathological factors did not differ between the two groups. The survival time for patients with a tumor in the anterior group was shorter than that for patients with a tumor in other areas (P < 0.05). The five-year survival rate was 79.3% for patients with an anterior tumor and 91.9% for those with a tumor at a different site. A multivariate analysis indicated lymph node metastasis, serosal invasion, and anterior wall location to be independent prognostic factors indicative of a poor prognosis when the tumor was located in the middle third of the stomach. For such patients, close follow-up is needed to detect possible recurrences. © 1993 Wiley-Liss, Inc. 相似文献
28.
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. 总被引:2,自引:0,他引:2
Andreas Fusshoeller Marcus Plail Bernd Grabensee Joerg Plum 《Nephrology, dialysis, transplantation》2004,19(8):2101-2106
BACKGROUND: In chronic ambulatory peritoneal dialysis, bicarbonate-buffered fluids, with their neutral pH and less advanced glycosylation end-products (AGE) and glucose degradation products (GDP), have better biocompatibility than conventional peritoneal dialysis (PD) solutions. That difference may be more beneficial in automated peritoneal dialysis (APD), due to its more frequent exchanges and longer contact times with fresh dialysate. We performed a prospective, randomized study in APD patients to compare the biocompatibility of conventional and bicarbonate/lactate-buffered PD fluids. METHODS: We randomized 14 APD patients to have APD with either conventional or bicarbonate/lactate-based fluids. After 6 months, both groups changed to the other solution. The overall observation period was 12 months. After 1 and 5 months and again after 7 and 11 months, phagocytotic and respiratory burst capacities of effluent peritoneal macrophages were determined. Plasma interleukin (IL)-6 and C-reactive protein (CRP) as well as effluent IL-6, CRP, transforming growth factor (TGF)-beta 1, AGE and CA125 concentrations were measured. Inflow pain was quantified using a patient questionnaire. RESULTS: Respiratory burst capacity remained unchanged and phagocytotic activity increased significantly during APD (P<0.001) with the bicarbonate/lactate fluid. Effluent IL-6 release was significantly lower than with the lactate fluid (P<0.05). While in the effluent TGF-beta 1 was unaffected, AGE concentration was lower after bicarbonate/lactate treatment (P<0.05). Effluent CA125 concentration, an indicator of mesothelial cell integrity, was higher (P<0.05) in neutral effluents. Finally, patients' inflow pain diminished (P = 0.05) when using the neutral fluid. CONCLUSIONS: The use of a neutral PD fluid in APD improved patients' inflow pain as well as biocompatibility parameters reflecting enhanced phagocytotic activity of peritoneal macrophages, reduced constitutive inflammatory stimulation (IL-6), reduced AGE accumulation in the peritoneal cavity and better preservation of the mesothelial cell integrity. From the biocompatibility point of view, a neutral fluid with low GDP content can be recommended as the primary choice for APD. 相似文献
29.
Satoshi Ogata Takayuki Naito Noriaki Yorioka Kei Kiribayashi Masatoshi Kuratsune Nobuoki Kohno 《Nephrology, dialysis, transplantation》2004,19(11):2831-2837
BACKGROUND: In patients on long-term continuous ambulatory peritoneal dialysis (CAPD), peritoneal dysfunction may occur due to loss of peritoneal mesothelial cells, peritoneal fibrosis and neovascularization. Lactate, long used as a buffer in peritoneal dialysates, has been substituted by bicarbonate in recent years. However, their effects on the peritoneum of CAPD patients are unknown. This study investigated the influence of lactate and bicarbonate on peritoneal dysfunction in CAPD patients. METHODS: The mitochondrial activity of human peritoneal mesothelial cells (HPMCs) and their expression of basic fibroblast growth factor (bFGF) were studied after culture under various conditions. We also assessed the mitochondrial-activating effect of the supernatant of those cultures on human peritoneal fibroblasts (HPFBs) and human umbilical vein endothelial cells (HUVECs) and the effect of recombinant human bFGF on the mitochondrial activity of HPFBs and HUVECs. We used the WST-1 assay to determine mitochondrial activity in HPMC. RESULTS: At pH 7.4, the mitochondrial activity of HPMCs was lowest in a medium containing 40 mM (Lac), intermediate in a lactate (15 mM) plus bicarbonate (25 mM) medium (Lac/Bic), and highest in a 40 mM bicarbonate medium (Bic). In culture supernatant, the increase of bFGF was: Lac > Lac/Bic > Bic. Mitochondrial activation of HPFBs and HUVECs was stimulated by HPMC culture supernatants in the following decreasing order: Lac > Lac/Bic > Bic. The effects of these supernatants were suppressed by a bFGF-neutralizing antibody, while recombinant bFGF caused concentration-dependent mitochondrial activation in HPFBs and HUVECs. CONCLUSIONS: The role of bFGF in peritoneal fibrosis and neovascularization may be important. A bicarbonate-containing medium is better than a lactate-containing medium for preserving cell viability in HPMCs and preventing bFGF expression by these cells. 相似文献
30.
Yamaji Yasuyoshi; Nakazato Yuichi; Oshima Naoki; Hayashi Matsuhiko; Saruta Takao 《Nephrology, dialysis, transplantation》2004,19(10):2592-2597
Background. Transferrin binds extracellular iron and protectstissues from iron-induced oxidative stress. The binding of ironand transferrin is pH dependent and conventional peritonealdialysis (PD) solutions have unphysiologically low pH values.Herein, we investigated whether conventional PD solution releasesiron from transferrin and if the released iron causes oxidativestress. Methods. Effects of PD solutions on iron binding to transferrinwere examined with purified human transferrin and transferrinin dialysates drained from PD patients. Oxidative stress inducedby iron released from transferrin was evaluated in terms ofthe formation of thiobarbituric acid reactive substance (TBARS)and protein carbonylation in the human red blood cell (RBC)membrane. The iron deposition in peritoneal tissue from PD patientswas evaluated by Perls' staining with diaminobenzidine intensification. Results. Low pH PD solution released iron from transferrin.This iron release occurred within 1 min. Iron release was notobserved in neutralized PD solution. Iron released from transferrinin low pH PD solution increased TBARS formation and proteincarbonylation in the human RBC membrane. Iron deposition, whichis prominent in the fibrotic area facing the peritoneal cavity,was observed in the peritoneum of PD patients. Conclusions. Iron released from transferrin in low pH PD solutioncan produce oxidative stress in the peritoneum of a PD patient.Neutralizing PD solution can avoid this problem. Iron depositionin the peritoneum may participate in the pathogenesis of peritonealfibrosis in PD patients. 相似文献